VIVIAN TRAN: Open Payments
NPI 1942902770 · OCEAN SPRINGS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$681 in 33 payments from 9 companies in 2025. Trend: 2023 $94 · 2024 $564 · 2025 $681
Food & beverage: $681
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 19 | $419 |
| Novartis Pharmaceuticals Corporation | 4 | $74 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $47 |
| Merck Sharp & Dohme LLC | 2 | $43 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| Corcept Therapeutics | 1 | $20 |
| Amgen Inc. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| CVRx, Inc. | 1 | $15 |
Products named: CAMZYOS, LEQVIO, Kerendia, EVKEEZA, VERQUVO, Korlym, CAPVAXIVE, REPATHA.
Industry payments across MS — which companies pay providers there.
